Since 2013, a number of studies have enhanced the literature and have guided clinicians on
viable treatment interventions outside of pharmacotherapy and surgery. Thirty‐three …

Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …

Introduction Research comparing levodopa/carbidopa intestinal gel (LCIG), deep brain
stimulation (DBS), and continuous subcutaneous apomorphine infusion (CSAI) for advanced …

Background: Optimal management in expert centers for Parkinson's disease (PD) usually
involves pharmacological and non-pharmacological interventions, delivered by a …

ParkinsonNet, a low-cost innovation to optimize care for patients with Parkinson disease,
was developed in 2004 as a network of physical therapists in several regions in the …

Parkinson's disease is a common neurodegenerative disorder, resulting in both motor and
non-motor symptoms that significantly reduce quality of life. Treatment consists of both …

Objective To test effects on care quality of Chronic Care Model-based Parkinson disease
(PD) management. Methods This 2-group stratified randomized trial involved 328 veterans …

Delivering healthcare to people living with Parkinson's disease (PD) may be challenging in
face of differentiated care needs during a PD journey and a growing complexity. In this …

Objective Communication technologies, such as personal online health communities, are
increasingly considered as a tool to realise patient empowerment. However, little is known …

Cognitive and behavioral symptoms are common in Parkinson's disease, may occur even in
the prodromal stages of the disease, worsen with disease progression, and surpass motor …